☄️Late breakingTRAIL1 RCT Pirfenidone on RA-ILD. ✨Primary outcome on incidence of decline of >10% FVC or death not met 11% PIR vs. 15% PBO OR=0.67 p=0.48 BUT ✨underpowered ✨reduces decline in FVC(ml) over 52wk (-66 vs. -146, p=0.0082) ✨safety ok #ACR21 #AbstL10 @RheumNow https://t.co/IxYDE3lN1s